Gonda et al., previously conducted an analytic and clinical validation study for the potential utility of PID particles in quantitating HER2 membrane protein in well characterized breast cancer cell lines that demonstrated a range of levels of HER2 expression. Here, ERBB2 is linked to breast cancer.